- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 111
Vay Sports kicks off with corporate funds
University of Zurich spinout Vay Sports has launched having raised an undisclosed amount from investors including Swisscom and WelcomeAI.
May 7, 2019Invert Robotics digs in for $8.8m
Inspection robot manufacturer Invert Robotics was founded out of University of Canterbury in 2011 and has now secured corporate Yamaha Motor as an investor in its latest round.
May 7, 2019UHZ stays fit with Vay Sports
Vay Sports has been spun out of University of Zurich to commercialise a fitness app that exploits computer vision to monitor a user's posture.
May 6, 2019Corporate venturing deal net: 29 April-3 May 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
May 3, 2019ClinSpec detects $2.1m
Scottish Investment Bank and Innovate UK were among those backing University of Strathclyde brain cancer diagnosis spinout ClinSpec Diagnostics.
May 2, 2019UCL helps put Odin Vision in the picture
UCL bowel cancer diagnostics spinout Odin Vision has attracted the UCL Technology Fund in a round that will support trials of its first computer vision-powered product.
Apr 30, 2019GoLiver goes forth with Satt Ouest Valorisation
Spun out of University of Nantes and research institute Inserm, GoLiver Therapeutics hopes to catalyse a stem cell-based regenerative drug candidate for the treatment of acute and chronic severe liver failure.
Apr 30, 2019GetYourGuide goes for series E funding
SoftBank is investing an amount reported to be approximately $556m in tour booking service GetYourGuide, though the company itself has not provided confirmation.
Apr 30, 2019Tencent ventures to Eastern Jinxin
Tencent has provided a nine-figure renminbi sum for Eastern Jinxin as part of a data research and development partnership with its cloud computing subsidiary.
Apr 30, 2019Navan sups on seed funding
Amgen is among the seed investors for Stanford-licensed drug release technology developer Navan Technologies, which hopes its nanoinjection technique will enable more cell and gene therapies to be produced at scale.
Apr 29, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


